Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-17 Sale | 2026-06-22 4:09 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 10,000 | $61.55 | $615,488 | 881,412 (Indirect Direct) | View |
| 2026-06-16 Sale | 2026-06-17 4:17 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 14,396 | $60.95 | $877,436 | 84,683 (Direct) | View |
| 2026-06-15 Sale | 2026-06-17 4:17 pm | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 2,954 | $62.08 | $183,384 | 2,233 (Direct) | View |
| 2026-06-15 Sale | 2026-06-17 4:17 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 12,500 | $62.12 | $776,495 | 106,786 (Direct) | View |
| 2026-03-20 Sale | 2026-03-24 5:05 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 2,989 | $66.75 | $199,516 | 83,266 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 12,274 | $68.36 | $839,070 | 35,028 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 12,440 | $68.36 | $850,417 | 63,959 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 11,324 | $68.21 | $772,444 | 86,255 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 13,056 | $68.36 | $892,528 | 61,480 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:04 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 1,144 | $68.36 | $78,204 | 41,708 (Indirect Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 6,430 | $68.36 | $439,566 | 43,316 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 7:03 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 34,603 | $68.34 | $2,364,904 | 891,412 (Indirect Direct) | View |
| 2026-03-16 Sale | 2026-03-18 4:11 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 12,500 | $68.79 | $859,819 | 116,332 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-25 Option Award | 2026-06-29 4:32 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 6,254 | $0 | 6,254 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:31 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 6,254 | $0 | 6,254 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:31 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 6,254 | $0 | 6,254 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:31 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 6,254 | $0 | 6,254 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:31 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 7,463 | $0 | 7,463 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:30 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | PYOTT DAVID E I Director | 7,060 | $0 | 7,060 (Direct) | View |
| 2026-06-25 Option Award | 2026-06-29 4:30 pm | N/A 2036-06-24 | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 7,060 | $0 | 7,060 (Direct) | View |
| 2026-06-15 Exercise | 2026-06-17 4:17 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 27,881 | $0 | 84,683 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 2,954 | $0 | 13,654 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 2,954 | $0 | 119,286 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 2,954 | $0 | 11,654 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:05 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 2,954 | $0 | 5,187 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:05 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 2,954 | $0 | 16,654 (Direct) | View |
| 2026-06-12 Exercise | 2026-06-16 4:05 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 2,954 | $0 | 19,654 (Direct) | View |
| 2026-04-24 Exercise | 2026-04-28 4:23 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | PYOTT DAVID E I Director | 1,383 | $0 | 9,374 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 47,818 | $0 | 83,969 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:38 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 48,472 | $0 | 113,066 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:35 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 52,574 | $0 | 136,834 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:32 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 52,964 | $0 | 115,298 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:27 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 26,084 | $0 | 80,853 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:24 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 132,548 | $0 | 1,033,867 (Direct) | View |
| 2026-03-15 Exercise | 2026-03-17 4:20 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 2,511 | $0 | 50,386 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2026-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 50,030 | $0 | 50,030 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 50,030 | $0 | 50,030 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 44,471 | $0 | 44,471 (Direct) | View |
| 2026-03-05 Option Award | 2026-03-09 4:06 pm | N/A 2036-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 44,471 | $0 | 44,471 (Direct) | View |